Introduction {#sec1-1}
============

Perioperative hyperglycemia has been associated with increased perioperative morbidity and mortality, thereby increasing hospital cost and resource utilization, in diabetic and nondiabetic patients undergoing coronary artery bypass grafting (CABG).\[[@ref1]\]

Severe hyperglycemia has been found to occur, even in nondiabetic patients, during stressful processes with limited cardiovascular reserve and inadequate perfusion, such as myocardial infarction and cardiac surgery.\[[@ref1][@ref2][@ref3][@ref4][@ref5][@ref6][@ref7][@ref8]\] In the early stages of shock, compensatory mechanisms are able to maintain blood flow to the important organs through peripheral vasoconstriction. Blood pressure, heart rate, arterial oxygen saturation, and urine output may be normal at this early stage although global tissue hypoperfusion (GTH) and lactic acidosis may occur.\[[@ref9][@ref10][@ref11]\] Organ dysfunction could result from the imbalance between oxygen demand and supply due to prolonged tissue hypoperfusion\[[@ref12][@ref13][@ref14][@ref15][@ref16][@ref17][@ref18][@ref19][@ref20]\] leading to increased cost and resource utilization.

Perioperative hyperglycemia being a common occurrence even in nondiabetic patients undergoing CABG; in our study, we hypothesized that this could be related to the occurrence of global tissue hypoperfusion. Combination of mixed venous oxygen saturation (SvO~2~) and arterial lactate levels has been used to detect GTH. We also sought to determine whether elevated blood glucose level can be used as a marker to detect GTH and hence raise suspicion of underlying GTH, even when it is not hemodynamically apparent, so as to allow early intervention.

Materials and Methods {#sec1-2}
=====================

We conducted a prospective observational study in the cardiothoracic operation theater (OT) and Intensive Care Unit (ICU) of our tertiary care teaching hospital between November 2015 and October 2016. Institutional Ethics Committee clearance was obtained beforehand. Being an observational study concerned with ascertaining the effectiveness of a possible diagnostic marker a formal sample size calculation was not done. We planned to recruit 100 consecutive adult nondiabetic patients undergoing elective off-pump CABG patients who fulfilled inclusion/exclusion criteria and provided written and informed consent. The selection criteria and working definitions we used have been listed in [Table 1](#T1){ref-type="table"}.

###### 

Subject selection criteria and working definitions used in the study

  Category                                                                                                                                                                                                                                                                                        Criteria and Definitions
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------
  Inclusion criteria\[[@ref1]\]                                                                                                                                                                                                                                                                   Adult subject of either sex aged between 35-70 years
  Patients posted for elective off-pump CABG                                                                                                                                                                                                                                                      
  Ejection fraction ≥30% measured within 6 weeks before surgery                                                                                                                                                                                                                                   
  Nondiabetic with HbA1C \<6%                                                                                                                                                                                                                                                                     
  Exclusion criteria\[[@ref1]\]                                                                                                                                                                                                                                                                   Left main stem coronary disease
  Associated heart valve pathology                                                                                                                                                                                                                                                                
  Intraoperative cardiac arrest                                                                                                                                                                                                                                                                   
  Massive perioperative bleeding                                                                                                                                                                                                                                                                  
  Presence of preoperative intra-aortic balloon pump                                                                                                                                                                                                                                              
  Presence of cardiogenic shock or arrest                                                                                                                                                                                                                                                         
  Preoperative vasopressor therapy                                                                                                                                                                                                                                                                
  Preoperative mechanical ventilation                                                                                                                                                                                                                                                             
  Unfavorable laboratory parameters, i.e., creatinine \>133 µmol/L (2.4 mg/dL), total bilirubin \>22 µmol/L (0.39 mg/dL), white blood cell count \>12,000/µL, or platelet count \<100,000 cells/µL immediately before surgery                                                                     
  Working definitions                                                                                                                                                                                                                                                                             GTH: SvO~2~ \<70% and arterial lactate level ≥2 mmol/L\[[@ref16]\]
  Moderate GTH: SvO2 \<70% and lactate ≥2- \<4 mmol/L\[[@ref16]\]                                                                                                                                                                                                                                 
  Severe GTH: SvO2 \<70% and lactate ≥4 mmol/L\[[@ref16]\]                                                                                                                                                                                                                                        
  Occult hypoperfusion: Moderate-to-severe GTH with MAP ≥65 mmHg, CVP ≥8 mmHg, and UO ≥0.5 mL/kg/h\[[@ref16]\]                                                                                                                                                                                    
  Overt tissue hypoperfusion: GTH with MAP \<65 mmHg, CVP\<8 mmHg and UO \<0.5 mL/kg/h\[[@ref16]\]                                                                                                                                                                                                
  Time of mechanical ventilation: Time from arrival in ICU postoperatively to extubation                                                                                                                                                                                                          
  Duration of ICU stay: Number of hours after surgery to discharge from ICU. Patients were discharged from ICU when apyrexial, hemodynamically stable and requiring minimal use of vasoactive medication; chest drain output \<1.5 mL/kg/h\[[@ref16]\]                                            
  Duration of hospital stay: Number of days after surgery to discharge from hospital\[[@ref16]\]                                                                                                                                                                                                  
  Massive perioperative bleeding: Bleeding requiring either transfusion of ≥5 U whole blood or packed red blood cells within a 48-h period or reoperation after closure of sternotomy for the purpose of controlling bleeding (also known as BARC Type 4 \[CABG-related\] bleeding)\[[@ref21]\]   
  Moderate-to-high dose inotrope use: Moderate inotrope support was defined by inotrope use 12-24 h and high dose inotrope support was defined by support \>24 h in this study                                                                                                                    
  Renal dysfunction or failure: Serum creatinine increase \>177 µmol/L (3.19 mg/dL), serum creatinine increase \>50%, or dialysis requirement\[[@ref16]\]                                                                                                                                         
  Prolonged ventilation: Ventilation after arrival in ICU for \>24 h\[[@ref22]\]                                                                                                                                                                                                                  

CABG: Coronary artery bypass grafting, HbA1c: Glycosylated hemoglobin, GTH: Global tissue hypoperfusion, SvO~2~: Mixed venous oxygen saturation, MAP: Mean arterial pressure, CVP: Central venous pressure, UO: Urine output, ICU: Intensive Care Unit, BARC: Bleeding Academic Research Consortium

Our objectives were to detect the occurrence of GTH whether or not hemodynamically apparent (occult hypoperfusion) in our study patients, to examine the effect GTH on arterial blood glucose level, and to examine whether blood glucose level can be used as a marker of occult tissue hypoperfusion in nondiabetic patients during and after elective off-pump CABG surgery. We also observed the total intraoperative blood loss in each patient,\[[@ref23]\] duration of postoperative mechanical ventilation, moderate-to-high dose inotrope use, ICU stay, postoperative hospital stay, and multiple organ dysfunction score (MODS)\[[@ref24]\] on days 1, 2, and 4 after surgery in each patient, together with occurrence of postoperative complications.

Data were collected from each patient at following predefined time points: preincision, i.e., immediately after induction of anesthesia and intubation, postprotamine, i.e., immediately after protamine administration, on arrival in ICU, 8 h after ICU arrival and 24 h after ICU arrival. Data captured included SvO~2~, arterial lactate, arterial blood glucose, and vital parameters such as heart rate, invasive mean arterial pressure (MAP), central venous pressure (CVP), mean pulmonary artery pressure (mPAP), oxygen saturation (SO~2~), and arterial blood gas (ABG) parameters as well as cumulative urine output (UO) in ml/kg/hour and perioperative bleeding. The data were collected by an anesthesiologist who was otherwise not involved in the intra- and post-operative management of the patient.

Anesthesia and monitoring were performed as per institutional protocol. Induction was done with intravenous opiate anesthetic (fentanyl 10--15 μg/kg) and intravenous thiopental (5--7 mg/kg). Intravenous rocuronium 1 mg/kg was used to achieve neuromuscular blockade. All patients were ventilated mechanically after intubation on 50% FiO~2~ using oxygen, nitrous oxide mixture in 0.5 MAC isoflurane. Vascular access was achieved through a radial artery catheter for measurement of arterial blood pressure and blood sampling for arterial blood gas analyses, a multi-lumen internal jugular catheter for measurement of CVP and for fluid/medication administration, a pulmonary artery (PA) catheter to measure PA pressures and draw blood sample for measuring SvO~2~. A Foley catheter with attached urometer was used to measure urine output and a nasopharyngeal temperature probe was employed to record body temperature. Two-lead electrocardiogram (leads II and V5) and BIS were also monitored continuously.

Postoperatively, the trachea was not extubated and shifted to ICU or recovery room using Bain\'s circuit and 100% oxygen for intermittent positive pressure ventilation. On arrival in the ICU, the patients were electively ventilated and managed by intensive care unit team following institutional protocol. Various parameters of the study as mentioned earlier were measured and recorded at the above-mentioned time points. Blood glucose value ≥180 mg/dL at any of the time points were corrected by intravenous bolus dose of human regular insulin in which case the glucose was rechecked ½ h later. Standard ICU protocol for postoperative care was followed. If cardiac index was \<2.5 L/min/m^2^ despite volume expansion to maintain a pulmonary capillary wedge pressure of 12--18 mmHg, dobutamine infusion was started. MAP was kept between 60 and 90 mmHg using dopamine or norepinephrine infusion.\[[@ref5]\] Patients with massive perioperative bleeding were excluded from the study, and in others, blood hemoglobin (Hb) level was kept between 7 and 9 g/dL, with transfusion threshold at Hb \<7 g/dL.\[[@ref25]\] Patients were weaned from mechanical ventilation and subsequently extubated on fulfilling extubation criteria.\[[@ref26]\]

Statistical analysis {#sec2-1}
--------------------

Numerical variables were compared between groups by Student\'s independent samples *t*-test. Fisher\'s exact test was employed for intergroup comparison of categorical variables. Two-tailed *P* ≤ 0.05 was considered for statistically significant.

The approach of analysis adopted in this research included exploring the relationship between postoperative outcome variables with GTH and non-GTH patients. For this purpose, binomial logistic regression and ordinal logistic regression were carried out using the software SPSS Statistic 20, IBM, Washington D.C., United States. When the data of the outcome variables were either nominal or categorical such as those of "duration of ventilation" (nominal), renal failure, cardiac shock, and occurrence of death (categorical) the binomial logistic regression was carried out. In case of ordinal data like the MODS score, ordinal logistic regression was carried out. The results displayed the predicted probability of the "occurrence of the input variables" against for "occurrence of GTH" as the outcome variable. The regression analysis was done in two stages. In the first stage, all parameters were considered for the analysis. However, unrealistic values of Exp (*B*) of the odds ratio of the output tables required a multicollinearity test between the input variables. After removing variables that may possibly have multicollinearity, the regression was freshly carried out to establish the parameter estimates (predicted probability) of the input variables. Higher values of the parameter estimates (*B*) indicate stronger relationships with GTH patients over others. Similarly, a positive coefficient indicates a positive relationship-meaning that with unit increase in input variable, the probability of having GTH increases. On the contrary, a negative relationship indicates lower chances of having GTH. The goodness of fit of these relationships were further tested through the Hosmer and Lemeshow Test, Nagelkerke *R*^2^ and Cox and Snell *R*^2^ values. A 95% confidence interval (CI) values have been considered here and a two-tailed *P* ≤ 0.05 was significance test carried out. Further, the relationship between changes in SvO~2~, lactate and glucose levels with the occurrence of GTH, was examined across five different time points including preincision stage, postprotamine stage, ICU baseline, ICU 8 h, and ICU 24 h stages. In this case, the predicted probability, however, was depicted against Non-GTH patients. Trend analysis was done, studying change in blood glucose levels with SvO~2~ levels in GTH and non-GTH patients across all 100 data points. Linear trend lines were then mapped on the scattered plot diagrams. A possible correlation was also explored with changes in SvO~2~, lactate and glucose levels, and outcome parameters across different time points. An *R*^2^ value close to 1 is considered to be a strong correlation and vice versa. A statistical significance analysis was also carried out validate the correlations thus established. Receiver operating characteristic (ROC) curve analysis was done to ascertain if a cutoff can be identified with respect to maximum observed blood glucose value for predicting occult tissue hypoperfusion.

Results {#sec1-3}
=======

Among 100 study participants, 67% (95% CI 57.78%--76.22%) encountered GTH at one or more time points. Among the 67 who experienced GTH, based on hemodynamic criteria, 7 experienced overt tissue hypoperfusion at one or more time points, and the remaining 60 experienced only occult tissue hypoperfusion.

The flowchart in [Figure 1](#F1){ref-type="fig"} summarizes these figures.

![Global tissue hypoxia and tissue perfusion status of the study subjects. GTH: global tissue hypoxia/hypoperfusion, SvO~2~: Mixed venous oxygen saturation](ACA-21-393-g001){#F1}

Demographics {#sec2-2}
------------

Mean age of patients with GTH (*n* = 67) was 57.7 ± 6.3 years and that of patients with no GTH (*n* = 33) was 54.4 ± 7.74 years; *P* = 0.024. Male:female ratio among patients with GTH was 59:8 and that in patients with no GTH was 27:6; *P* = 0.398. Mean fasting blood sugar of patients with GTH (*n* = 67) was 115.2 ± 16.62 mg/dl and that of patients with no GTH was 98.9 ± 14.86 mg/dl; *P* \< 0.001.

Individual arterial blood glucose level at various time points {#sec2-3}
--------------------------------------------------------------

From [Table 2](#T2){ref-type="table"}, blood glucose levels were found to be higher for GTH patients compared to no GTH patients across preincision, ICU baseline, and ICU 8 h time points.

###### 

Changes in mixed venous oxygen saturation, lactate and glucose levels in no global tissue hypoxia or hypoperfusion versus global tissue hypoxia or hypoperfusion subgroups over time

                               GTH patients   Non-GTH patients                                           
  ---------------------------- -------------- ------------------ -------------- ------------ ----------- --------------
  Preincision                                                                                            
   Mean±SD                     63.33±4.27     2.56±0.25          128.50±12.85   76.64±7.07   1.26±0.82   108.57±18.24
   *t*                         34.56          20.58              20.07          105.33       14.71       57.11
   df                          4              4                  4              92           92          92
  Significance (two-tailed)    0.000          0.000              0.000          0.000        0.000       0.000
  Postprotamine                                                                                          
   Mean±SD                     61.44±6.89     4.17±1.12          166.00±24.14   79.42±7.68   3.42±1.92   165.00±23.82
   *t*                         24.46          9.94               20.12          97.85        16.77       65.36
   df                          7              7                  7              89           89          89
   Significance (two-tailed)   0.000          0.000              0.000          0.000        0.000       0.000
  ICU baseline                                                                                           
   Mean±SD                     59.87±6.75     4.94±1.75          184.00±7.89    78.54±7.38   4.14±1.92   167.73±25.33
   *t*                         34.11          10.24              85.55          97.01        19.62       60.32
   df                          13             13                 13             83           83          83
   Significance (two-tailed)   0.000          0.000              0.000          0.000        0.000       0.000
  ICU 8 h                                                                                                
   Mean±SD                     62.53±5.53     5.22±1.39          177.37±12.95   74.81±6.00   4.55±1.96   170.23±22.49
   *t*                         71.96          26.00              92.94          82.24        15.43       48.47
   df                          46             46                 46             41           41          41
   Significance (two-tailed)   0.000          0.000              0.000          0.000        0.000       0.000
  ICU 24 h                                                                                               
   Mean±SD                     62.48±4.97     3.05±0.95          147.94±19.23   70.81±7.92   2.68±1.63   151.10±17.70
   *t*                         70.38          17.88              43.09          72.13        13.28       69.98
   df                          31             31                 31             65           65          65
   Significance (two-tailed)   0.000          0.000              0.000          0.000        0.000       0.000

GTH: Global tissue hypoxia or hypoperfusion, SvO~2~: Mixed venous oxygen saturation, SD: Standard deviation, df: Degree of freedom, ICU: Intensive Care Unit

Trend analysis of blood glucose levels against mixed venous oxygen saturation and lactate levels, across different time points {#sec2-4}
------------------------------------------------------------------------------------------------------------------------------

[Figure 2](#F2){ref-type="fig"} shows the Trend Analysis of the performance of blood glucose levels in GTH patients against SvO~2~ and lactate levels, across different time points. Results show that during postprotamine and ICU baseline time points, the blood glucose levels in GTH patients decrease with increase in SvO~2~ levels. In case of lactate levels, results show a steep rise in blood glucose levels with increasing lactate levels during the preincision period, whereas the blood glucose levels moderately increase with increasing lactate levels across all time points.

![Trend analysis in GTH patients](ACA-21-393-g002){#F2}

[Figure 3](#F3){ref-type="fig"} shows the Trend Analysis of the performance of blood glucose levels in non-GTH patients against SvO~2~ and Lactate levels, across different time points. Results show a steep upward trend in the blood glucose levels in Non-GTH patients with increase in SvO~2~ levels, whereas the blood glucose levels are nearly stable with increase in SvO~2~ levels across other time points. In case of lactate levels, results indicate stable blood glucose levels with increasing lactate levels in non-GTH patients, across all time points.

![Trend analysis in non-GTH patients](ACA-21-393-g003){#F3}

Arterial blood glucose level as a marker for occult tissue hypoperfusion {#sec2-5}
------------------------------------------------------------------------

The proportion of patients who encountered occult tissue hypoperfusion in this study was 60% (95% CI 56.72%--75.28%). ROC curve analysis suggested that with a cutoff of ≤183 mg/dL, occult tissue hypoperfusion can be predicted with 54.6% sensitivity (95% CI 41.8%--66.9%) and 60.6% specificity (95% CI 42.1%--77.1%). However, the sensitivity and specificity figures are not high enough to make the cutoff clinically meaningful. The area under the ROC curve was 0.571 (95% CI 0.467--0.670) which also suggests that this cutoff can only be of limited clinical utility.

Relationship of GTH with postoperative outcome {#sec2-6}
----------------------------------------------

From [Table 3](#T3){ref-type="table"}, GTH patients had higher MODS day 1 score, longer duration in ICU or hospital (highest correlation), increased operative blood loss.

###### 

Relationship between postoperative outcome variables (nominal and ordinal data) and global tissue hypoxia or hypoperfusion patients: Results using ordinal logistic regression

                             *B* (parameter coefficient)   SE      Wald     df   Significance value   CI
  -------------------------- ----------------------------- ------- -------- ---- -------------------- -----
  GTH                        11.447                        5.185   4.874    1    0.027                95%
  ICU stay                   0.094                         0.060   2.485    1    0.115                95%
  Perioperative blood loss   0.004                         0.002   3.444    1    0.063                95%
  Hospital stay              3.164                         0.808   15.349   1    0.000                95%
  MODS score for day 1       −9.705                        0.000            1                         95%
  MODS score for day 2       0^a^                                           0                         95%

^a^This parameter is set to zero because it is redundant. df: Degrees of freedom, *B*: Parameter coefficient, Wald: Wald coefficient, SE: Standard error, CI: Confidence interval, GTH: Global tissue hypoxia or hypoperfusion, ICU: Intensive Care Unit, MODS: Multiple organ dysfunction score

From [Table 4](#T4){ref-type="table"}, the Odds Ratio for predictor variable duration of ventilation shows that GTH patients had increased duration of ventilation.

###### 

Relationship between postoperative outcome variables (nominal and categorical data) and global tissue hypoxia or hypoperfusion patients: Results using logistic regression)

                                      *B*     SE           Wald     df   Significance value   Exp (*B*)   CI
  ----------------------------------- ------- ------------ -------- ---- -------------------- ----------- -----
  Duration of ventilation             0.215   0.114        3.550    1    0.060                1.240       95%
  Moderate-to-high dose of inotrope   0.342   1.152        14.210   1    0.000                1.013       95%
  cardiac shock                       0.485   27,998.549   0.000    1    1.000                1.625       95%
  Constant                            0.210   27,998.550   0.000    1    1.000                1.233       95%

Predicted probability is for GTH (outcome variable). Exp (B) equivalent to Odds Ratio. df: Degrees of freedom, *B*: Parameter coefficient, Wald: Wald coefficient, OR: Odds ratio, SE: Standard error, CI: Confidence interval, GTH: Global tissue hypoxia or hypoperfusion

Correlation of individual mixed venous oxygen saturation, arterial lactate, and arterial blood glucose levels at various time points with postoperative outcome {#sec2-7}
---------------------------------------------------------------------------------------------------------------------------------------------------------------

[Table 5](#T5){ref-type="table"} shows that SvO~2~ at time point 24 h in ICU, has significant negative correlation with duration of inotrope use (*r* = −0.431, *P* = 0.000). Lactate level at preincision time point, have positive correlation with multi-organ dysfunction score on day 1 (ρ = 0.171, *P* = 0.089). Blood glucose level at postprotamine time point has significant positive correlation with duration of inotrope use (*r* = 0.221, *P* = 0.027).

###### 

Correlation of mixed venous oxygen saturation, lactate and glucose levels at various time points with postoperative outcome parameters

  Variables                        Preincision      Postprotamine    ICU at arrival   ICU at 8 h       ICU at 24 h
  -------------------------------- ---------------- ---------------- ---------------- ---------------- ----------------
  SvO2 (%)                         75.84±7.61       77.80±9.18       75.74±9.88       67.67±8.62       68.06±8.08
   Duration of ventilation (h)     −0.270 (0.006)   −0.324 (0.001)   −0.398 (0.000)   −0.320 (0.001)   −0.318 (0.001)
   ICU stay (h)                    −0.263 (0.008)   −0.343 (0.000)   −0.390 (0.000)   −0.367 (0.000)   −0.427 (0.000)
   Hospital stay (days)            −0.177 (0.077)   −0.209 (0.037)   −0.363 (0.000)   −0.336 (0.001)   −0.367 (0.000)
   MODS day 1                      −0.056 (0.577)   −0.044 (0.665)   −0.090 (0.374)   −0.145 (0.150)   −0.275 (0.006)
   MODS day 2                      −0.209 (0.037)   −0.186 (0.064)   −0.196 (0.051)   −0.129 (0.201)   −0.166 (0.099)
   MODS day 4                      −0.162 (0.107)   −0.155 (0.123)   −0.138 (0.172)   −0.134 (0.183)   −0.117 (0.247)
   Duration of inotrope use (h)    −0.192 (0.056)   −0.273 (0.006)   −0.428 (0.000)   −0.386 (0.000)   −0.431 (0.000)
   Perioperative blood loss (mL)   −0.107 (0.289)   −0.096 (0.342)   −0.026 (0.796)   0.014 (0.894)    0.043 (0.669)
  Lactate (mmol/L)                 1.33±0.85        3.48±1.87        4.25±1.91        4.84±1.65        2.80±1.45
   Duration of ventilation (h)     0.076 (0.455)    0.073 (0.468)    0.108 (0.283)    0.073 (0.473)    0.083 (0.411)
   ICU stay (h)                    0.050 (0.624)    0.006 (0.956)    0.030 (0.764)    −0.003 (0.975)   0.037 (0.717)
   Hospital stay (days)            −0.055 (0.588)   0.046 (0.648)    0.038 (0.710)    0.075 (0.460)    0.023 (0.824)
   MODS day 1                      0.171 (0.089)    −0.072 (0.475)   0.021 (0.838)    0.063 (0.535)    0.052 (0.604)
   MODS day 2                      0.001 (0.990)    0.114 (0.259)    0.077 (0.448)    0.092 (0.365)    0.152 (0.131)
   MODS day 4                      0.145 (0.151)    0.134 (0.184)    0.141 (0.162)    0.145 (0.151)    0.115 (0.255)
   Duration of inotrope use (h)    0.081 (0.423)    0.120 (0.234)    0.102 (0.311)    0.053 (0.602)    0.100 (0.322)
   Perioperative blood loss (mL)   −0.058 (0.569)   −0.064 (0.525)   0.024 (0.813)    0.044 (0.663)    0.144 (0.153)
  Glucose (mg/dL)                  109.77±18.53     165.09±23.72     170.17±24.23     180.98±16.55     150.06±18.18
   Duration of ventilation (h)     0.154 (0.127)    0.168 (0.094)    0.108 (0.286)    0.127 (0.209)    0.123 (0.225)
   ICU stay (h)                    0.118 (0.242)    0.159 (0.115)    0.077 (0.445)    0.111 (0.271)    0.048 (0.633)
   Hospital stay (days)            −0.005 (0.957)   0.116 (0.251)    0.071 (0.480)    0.127 (0.210)    0.058 (0.564)
   MODS day 1                      0.093 (0.357)    0.083 (0.409)    0.092 (0.361)    0.194 (0.053)    −0.042 (0.677)
   MODS day 2                      0.125 (0.215)    0.183 (0.068)    0.132 (0.189)    0.099 (0.327)    0.121 (0.229)
   MODS day 4                      0.150 (0.137)    0.134 (0.184)    0.084 (0.408)    0.108 (0.285)    0.136 (0.178)
   Duration of inotrope use (h)    0.102 (0.312)    0.221 (0.027)    0.106 (0.295)    0.139 (0.167)    0.086 (0.393)
   Perioperative blood loss (mL)   −0.004 (0.967)   0.118 (0.242)    0.076 (0.454)    −0.088 (0.384)   0.083 (0.410)

Values of SvO~2~, lactate and glucose levels are indicated as mean±SD. Other values indicate Pearson correlation coefficient *r* with the *P* value from hypothesis test of correlation in brackets for continuous variable including a) duration of ventilation, b) duration of stay in ICU, c) total duration of stay in hospital, d) duration of inotrope use, and e) perioperative blood loss. For ordinal data like MODS for day 1, day 2, and day 3, Spearman\'s correlation coefficient (ρ) has been used with the *P* value from hypothesis test of correlation in brackets. The *r* or ρ values have been interpreted as follows: ≥7.0 implies strong correlation; 0.5-0.7 implies good correlation; 0.3-0.5 implies moderate correlation and \<0.3 implies poor correlation. Associated *P*\<0.05 implies that the correlation observed in the sample is significant and that it is most likely to hold true for the underlying population. SD: Standard deviation, ICU: Intensive Care Unit, MODS: Multiple organ dysfunction score, SvO~2~: Mixed venous oxygen saturation

Discussion {#sec1-4}
==========

Overall tissue oxygen demand, if not met by adequate oxygen delivery by an optimal circulation, may lead to the state of global tissue hypoxia and act as a harbinger of multiorgan damage and failure when not managed appropriately at an early stage.\[[@ref9][@ref13][@ref14][@ref15][@ref16]\] Mixed venous oxygen saturation and arterial lactate values may indicate GTH early, before conventional monitoring parameters, such as blood pressure and urine output, would indicate the same. Xu *et al*.\[[@ref11]\] have documented significantly shorter hospital stay and lower ICU readmission rate in postcoronary bypass and valve surgery patients in whom hypoperfusion was detected at an occult stage (ScvO~2~ \<70%, lactate ≥2 mmol/L, and blood pressure ≥90 mmHg) and treated according to a standard protocol. In our study, combined markers of SvO~2~ and arterial lactate level were used to detect global tissue hypoperfusion (GTH) as per predefined criteria. GTH was detected in 67% of patients at one or more time points, with 55% having severe GTH at some point. The incidence of occult tissue hypoperfusion was 60%.

From previous studies, perioperative hyperglycemia appears to be common even in nondiabetic patients undergoing CABG both on-pump and off-pump. In a prospective observational study, Azarfarin *et al*.\[[@ref27]\] found the prevalence of hyperglycemia (blood glucose ≥126 mg/dL) in 95% and severe hyperglycemia (blood glucose ≥180 mg/dL) in 54.6% of nondiabetic patients undergoing CABG. There was not much of a difference in the prevalence and intensity of hyperglycemia in patients undergoing CABG on-pump versus off-pump. One possible explanation for the rise in glucose could be inadequate circulation and consequent inadequate global perfusion and release of stress hormones. This being the hypothesis of our study comprising nondiabetic patients undergoing elective off-pump CABG, we identified subjects who encountered GTH and occult tissue hypoperfusion (those with GTH but apparently normal hemodynamics) and studied their arterial blood glucose level at various study time points. About 80% of our total study population reported high blood glucose level (\>180 mg/dl) at some point or the other. About 25.3% of GTH patients reported high blood glucose level at postprotamine period, 40.2% of GTH patients at ICU baseline time point, 64.2% of GTH patients at ICU 8 h time point, and 0.01% of patients at ICU 24 h time point. Blood glucose levels were found to be higher for GTH patients compared to No GTH patients across preincision, ICU baseline and ICU 8 h time points. Therefore, raised blood glucose levels were found in most GTH patients post revascularization.

Trend Analysis of the performance of blood glucose levels in GTH patients against SvO~2~ and Lactate levels, across different time points, show that during postprotamine and ICU baseline time points, the blood glucose levels in GTH patients decrease with increase in SvO~2~ levels. In case of lactate levels, results show a steep rise in blood glucose levels with increasing lactate levels during preincision period, whereas the blood glucose levels moderately increase with increasing lactate levels across all time points. Therefore, in our study, increase in blood glucose level coincided with decrease in SvO~2~ and increase in blood lactate level. The latter two being proven markers of GTH, the above findings go a long way in supporting our hypothesis that perioperative hyperglycemia is related to global tissue hypoperfusion.

Therefore, a possible explanation for the comparatively higher blood glucose level in the particular group of patients at certain time points could be due to global tissue hypoperfusion experienced by them at those points in time.

We took a step further to determine whether elevated blood glucose level can be used as a marker to detect GTH. However, the low sensitivity and specificity values we found implies that blood glucose level cannot be treated as marker of GTH and occult hypoperfusion in nondiabetic patients undergoing elective off pump-CABG, although it bears a relation to the occurrence of GTH. This could be because of factors other than global tissue hypoperfusion also contributing to the increase in blood glucose level.

Estrada *et al*.\[[@ref1]\] have opined that the occurrence of perioperative hyperglycemia in nondiabetic patients undergoing CABG may be explained by stress hyperglycemia, glucose intolerance, or undiagnosed diabetes.

To summarize, postoperative outcome including complications in our study, patients with GTH spent longer duration in hospital and ICU, had higher operative blood loss and had higher MODS scores. Furthermore, patients with GTH had significantly long duration of ventilation, had high dose of inotrope use and were more likely to suffer a cardiac arrest.

Hu *et al*.\[[@ref16]\] in their study, found that lactate at 24 h positively correlated with MODS on days 1, 2, and 7, ICU length of stay, and postoperative hospital stay. In our study, SvO~2~ at time point, 24 h in ICU, had significant negative correlation with duration of inotrope use, underlining the obvious fact that patients with inadequate circulation due to low cardiac output will require high dose of inotropes. Lactate level at preincision time point had a positive correlation with multi-organ dysfunction score on day 1. Blood glucose level at postprotamine time point had significant positive correlation with duration of inotrope use.

Conclusions {#sec1-5}
===========

Global tissue hypoperfusion, identified using the combined markers of SvO~2~ and lactate, was found to be a common occurrence in our study comprising nondiabetic patients undergoing elective off-pump CABG. The proportion of patients encountering occult tissue hypoperfusion was also high.

Our study finding also suggests that rise in blood glucose level in nondiabetic patients undergoing OPCABG may be an indicator of inadequate perfusion, raising the bar of suspicion for the same for the attending Cardiac Anaesthesiologist to initiate early intervention.

However, we are not able to propose elevated blood glucose level as a perioperative marker for GTH and occult tissue hypoperfusion. The confounding effect of other factors may be overshadowing the association between blood glucose and global tissue hypoperfusion. The exploration of blood glucose in conjunction with other factors will be the subject for further study.

Study limitations {#sec2-8}
-----------------

Our study findings may need to be validated on a larger sample size before extrapolation and application in routine practice. In addition, in our study, due to logistic reasons, more than one cardiac surgeon, each with different surgical practice, performed the off-pump CABG surgeries, and this was not controlled for.
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